Boyce S - Search Results

1

Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.

Seabrook GR, Sutton KG, Jarolimek W, Hollingworth GJ, Teague S, Webb J, Clark N, Boyce S, Kerby J, Ali Z, Chou M, Middleton R, Kaczorowski G, Jones AB. Seabrook GR, et al. Among authors: boyce s. J Pharmacol Exp Ther. 2002 Dec;303(3):1052-60. doi: 10.1124/jpet.102.040394. J Pharmacol Exp Ther. 2002. PMID: 12438527

2

Inhibition of acute nociceptive responses in rat spinal cord by a bradykinin B1 receptor antagonist.

Conley RK, Wheeldon A, Webb JK, DiPardo RM, Homnick CF, Bock MG, Chen TB, Chang RS, Pettibone DJ, Boyce S. Conley RK, et al. Among authors: boyce s. Eur J Pharmacol. 2005 Dec 19;527(1-3):44-51. doi: 10.1016/j.ejphar.2005.06.057. Epub 2005 Nov 28. Eur J Pharmacol. 2005. PMID: 16310181

3

Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.

Rupniak NM, Boyce S, Williams AR, Cook G, Longmore J, Seabrook GR, Caeser M, Iversen SD, Hill RG. Rupniak NM, et al. Among authors: boyce s. Br J Pharmacol. 1993 Dec;110(4):1607-13. doi: 10.1111/j.1476-5381.1993.tb14008.x. Br J Pharmacol. 1993. PMID: 8306108 Free PMC article.

4

Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils.

Rupniak NM, Webb JK, Williams AR, Carlson E, Boyce S, Hill RG. Rupniak NM, et al. Among authors: boyce s. Br J Pharmacol. 1995 Sep;116(2):1937-43. doi: 10.1111/j.1476-5381.1995.tb16686.x. Br J Pharmacol. 1995. PMID: 8528583 Free PMC article.

5

Inhibition of pentagastrin-induced pressor response in conscious rats by the CCK-B receptor antagonist CI-988 and chlordiazepoxide.

Webb JK, Rupniak NM, Boyce S. Webb JK, et al. Among authors: boyce s. Regul Pept. 1996 Jan 16;61(1):71-6. doi: 10.1016/0167-0115(95)00140-9. Regul Pept. 1996. PMID: 8701030

6

Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils.

Rupniak NMJ, Carlson E, Boyce S, Webb JK, Hill RG. Rupniak NMJ, et al. Among authors: boyce s. Pain. 1996 Sep;67(1):189-195. doi: 10.1016/0304-3959(96)03109-0. Pain. 1996. PMID: 8895247

7

The search for novel TRPV1-antagonists: from carboxamides to benzimidazoles and indazolones.

Fletcher SR, McIver E, Lewis S, Burkamp F, Leech C, Mason G, Boyce S, Morrison D, Richards G, Sutton K, Jones AB. Fletcher SR, et al. Among authors: boyce s. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2872-6. doi: 10.1016/j.bmcl.2006.03.004. Epub 2006 Mar 24. Bioorg Med Chem Lett. 2006. PMID: 16563760

8

Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels.

Clark NC, Nagano N, Kuenzi FM, Jarolimek W, Huber I, Walter D, Wietzorrek G, Boyce S, Kullmann DM, Striessnig J, Seabrook GR. Clark NC, et al. Among authors: boyce s. Neuroscience. 2003;120(2):435-42. doi: 10.1016/s0306-4522(03)00329-4. Neuroscience. 2003. PMID: 12890513

9

Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl.

Boyce S, Webb JK, Carlson E, Rupniak NM, Hill RG, Martin JE. Boyce S, et al. Exp Neurol. 1999 Jan;155(1):49-58. doi: 10.1006/exnr.1998.6873. Exp Neurol. 1999. PMID: 9918704

10

The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils.

Rupniak NM, Webb JK, Fisher A, Smith D, Boyce S. Rupniak NM, et al. Among authors: boyce s. Neuropharmacology. 2003 Mar;44(4):516-23. doi: 10.1016/s0028-3908(03)00023-6. Neuropharmacology. 2003. PMID: 12646288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

606 results

Search Page